New Zealand markets open in 5 hours 41 minutes

Microbot Medical Inc. (MBOT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.01000.0000 (0.00%)
As of 11:37AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close1.0100
Bid0.9703 x 100
Ask1.0600 x 100
Day's range1.0100 - 1.0399
52-week range0.8600 - 3.6600
Avg. volume97,537
Market cap14.543M
Beta (5Y monthly)1.70
PE ratio (TTM)N/A
EPS (TTM)-0.8600
Earnings date12 Aug 2024 - 16 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est7.00
  • GlobeNewswire

    Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™

    The next step of the collaboration will explore potential future applications of the LIBERTY system, including its potential capabilities for remote endovascular proceduresBRAINTREE, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today reports that the first phase of the previously announced collaboration with Corewell Health has been completed, which demonstrated the LIBERTY® System's tec

  • GlobeNewswire

    Microbot Medical Shares Status Following Recent Geopolitical Events

    All Regulatory, Clinical, Operational and Pre-Commercial Activities Continue to Stay on Track Despite the On-going Situation in Israel Company Believes that Both Regulatory and Commercial Milestones to be Achieved in Accordance with the Company’s Current Timeline BRAINTREE, Mass., April 15, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the LIBERTY® Endovascular Robotic Surgical System, today shared that despite the unprecedented events in Israel yesterday, which are

  • Zacks

    Microbot Medical (MBOT) Files IDE to Start Human Clinical Study

    Microbot Medical (MBOT) files an IDE with the FDA, approval of which will enable the company to proceed with its human clinical study in the United States.